Andreia Peixoto graduated in Biochemistry by the Faculty of Sciences UPorto in 2012 and completed her MSc degree in Biochemistry at the same institution in 2014, where she received a merit scholarship for exceptional academic performance. During her Master and PhD, Andreia Peixoto initiated her studies on cell-surface protein glycosylation associated with malignant transformations of the urinary bladder, envisaging biomarkers discovery for theragnostic applications. During her Master and PhD, as a member of Experimental Pathology and Therapeutics Group (IPO-Porto) and Tumour and Microenvironments Interactions group (INEB), she got familiarized with state-of-the-art in vitro techniques, trough the collaboration with IPATIMUP (Institute of Molecular Pathology and Immunology of the University of Porto). Currently, she is a Junior Researcher at IPO-Porto (CI-IPOP) and i3S pursuing advanced stage bladder cancer glycobiomarkers associated with hypoxia-mediated immunosuppressive microenvironments. In this context, she has proficiency in glycomics and glycoproteomics workflows as well as in novel gene editing technologies amd immuno-oncology. She often lectures to BSc and MSc students from polytechnic health school and actively participates in glycobiology meetings and workshops. She holds 2 book chapters and 26 publications (30% as first author; 746 citations; H-index: 15; i10-index:18) in relevant peer-reviewed journals in glycobiology/proteomics, oncoglycobiology, cancer biomarkers and therapeutics. As part of an Oncology Center of Excellence, her research presents a strong translational and market-oriented character, which is expected to translate into novel glycan-based cancer tools.